Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tracking 500 COPD patients on new treatment for 3 years

NCT ID NCT07380711

Recruiting now Knowledge-focused Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study aims to observe how COPD patients fare while taking the medication dupilumab in real-world medical settings. Researchers will follow about 500 participants in France for three years to collect information about their health, symptoms, and any side effects. The study does not test a new treatment—it simply observes patients who are already prescribed dupilumab by their doctors as part of routine care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Investigational Site Number : 2500001

    RECRUITING

    Pessac, 33604, France

  • Investigational Site Number : 2500002

    RECRUITING

    Montpellier, 34090, France

  • Investigational Site Number : 2500009

    RECRUITING

    Colmar, 68024, France

  • Investigational Site Number : 2500010

    RECRUITING

    Vantoux, 57070, France

  • Investigational Site Number : 2500017

    RECRUITING

    Paris, 400026, France

  • Investigational Site Number : 2500020

    RECRUITING

    Le Chesnay, 78157, France

  • Investigational Site Number : 2500021

    RECRUITING

    Aix-en-Provence, 13616, France

  • Investigational Site Number : 2500022

    RECRUITING

    Juan-les-Pins, 06600, France

  • Investigational Site Number : 2500024

    RECRUITING

    Marseille, 13003, France

  • Investigational Site Number : 2500026

    RECRUITING

    Nîmes, 30029, France

  • Investigational Site Number : 2500029

    RECRUITING

    Toulouse, 31076, France

  • Investigational Site Number : 2500033

    RECRUITING

    Lyon, 69008, France

  • Investigational Site Number : 2500034

    RECRUITING

    Pierre-Bénite, 69495, France

  • Investigational Site Number : 2500035

    RECRUITING

    Villeurbanne, 69100, France

  • Investigational Site Number : 2500038

    RECRUITING

    Libourne, 33500, France

  • Investigational Site Number : 2500040

    RECRUITING

    Niort, 79021, France

  • Investigational Site Number : 2500043

    RECRUITING

    Blois, 41016, France

  • Investigational Site Number : 2500044

    RECRUITING

    Brest, 29200, France

  • Investigational Site Number : 2500047

    RECRUITING

    Morlaix, 29600, France

  • Investigational Site Number : 2500048

    RECRUITING

    Saint-Pierre, 97448, France

Conditions

Explore the condition pages connected to this study.

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)